ENOV Stock: Price, Earnings History and SEC Filings
Enovis Corporation (ENOV) last traded at $19.91, down 12.71% on the latest session and up 9.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.76 against an analyst estimate of $0.79, a miss of 3.8%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ENOV earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.76 | $0.79 | -3.80% |
| Mar 2026 | May 7, 2026 | $0.89 | $0.82 | +8.54% |
| Dec 2025 | Feb 26, 2026 | $0.95 | $0.81 | +17.28% |
| Sep 2025 | Nov 6, 2025 | $0.75 | $0.67 | +11.94% |
ENOV beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How ENOV reacts to earnings
Across its last 8 earnings releases, ENOV moved 9.2% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | Before open | -12.82% |
| 2026-05-07 | Before open | +9.66% |
| 2026-02-26 | Before open | +13.89% |
| 2025-11-06 | Before open | -9.75% |
| 2025-08-07 | Before open | +10.71% |
| 2025-05-08 | Before open | -3.39% |
| 2025-02-26 | Before open | -4.99% |
| 2024-11-06 | Before open | +8.29% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
ENOV financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2.2B | -$1.2B | $20M | -52.7% | $-20.75 |
| 2024 | $2.1B | -$825M | -$67M | -39.2% | $-14.93 |
| 2023 | $1.7B | -$33M | $13M | -1.9% | $-0.61 |
| 2022 | $1.6B | -$13M | -$161M | -0.9% | $-0.25 |
| 2021 | $1.4B | $72M | $252M | 5.0% | $1.40 |
| 2020 | $1.1B | $43M | $187M | 3.8% | $0.93 |
| 2019 | $3.3B | -$528M | $6M | -15.9% | $-3.89 |
| 2018 | $2.2B | $140M | $157M | 6.4% | $1.16 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ENOV
- 8-K · Sep 1, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Aug 6, 2026
- 8-K · Aug 6, 2026Results of operations, Financial statements and exhibits
- 8-K · May 19, 2026Officer or director change, Shareholder vote, Financial statements and exhibits
- 10-Q · May 7, 2026
- 8-K · May 7, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 6, 2026
- 10-K · Feb 26, 2026
- 8-K · Feb 26, 2026Results of operations, Financial statements and exhibits
- 8-K · Jan 12, 2026Regulation FD disclosure, Financial statements and exhibits
Insider filing activity
ENOV insiders filed 4 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ENOV news
- Enovis (ENOV) Stock May Be 39% Undervalued On Cash FlowOct 24, 2026 · finance.yahoo.com
- 1 value stock worth investigating and 2 we questionOct 23, 2026 · finance.yahoo.com
- PRISM MarketView Highlights Five Innovative Public Companies Supporting Strength and Mobility for National Physical Therapy MonthOct 22, 2026 · finance.yahoo.com
- 1 Unprofitable Stock on Our Buy List and 2 We Turn DownOct 21, 2026 · finance.yahoo.com
About Enovis Corporation
Enovis Corporation (ENOV) is a US-listed public company on NYSE. The SEC classifies its business as Orthopedic Prosthetic & Surgical Appliances & Supplies. It is incorporated in DE. Its fiscal year ends in December.